A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer (Q46468999)
Jump to navigation
Jump to search
scientific article published in May 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer |
scientific article published in May 2005 |
Statements
1 reference
A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer (English)
1 reference
Jose Baselga
1 reference
Kathy D Miller
1 reference
George Sledge
1 reference
Jose Manuel Trigo
1 reference
Catherine Wheeler
1 reference
Alan Barge
1 reference
Jacqui Rowbottom
1 reference
1 May 2005
1 reference
1 reference
11
1 reference
3369-3376
1 reference
9
1 reference
Identifiers
1 reference
1 reference